Perspectives for personalized therapy for patients with multidrug-resistant tuberculosis-Reference-Cited by-同舟云学术

Perspectives for personalized therapy for patients with multidrug-resistant tuberculosis

Published:2018-07-11 Issue:2 Volume:284 Page:163-188
ISSN:0954-6820
Container-title:Journal of Internal Medicine
language:en
Short-container-title:J Intern Med

Author:

Lange C.¹²³⁴^ORCID,Alghamdi W. A.⁵^ORCID,Al-Shaer M. H.⁵^ORCID,Brighenti S.⁶^ORCID,Diacon A. H.⁷⁸,DiNardo A. R.⁹,Grobbel H. P.¹²³,Gröschel M. I.¹⁰¹¹,von Groote-Bidlingmaier F.⁷,Hauptmann M.²¹²,Heyckendorf J.¹²³,Köhler N.¹²³,Kohl T. A.¹¹,Merker M.¹¹,Niemann S.²¹¹,Peloquin C. A.⁵,Reimann M.¹²³,Schaible U. E.²¹²¹³¹⁴,Schaub D.¹²³,Schleusener V.¹¹,Thye T.¹⁵,Schön T.¹⁶¹⁷

Affiliation:

1. Clinical Infectious Diseases; Research Center Borstel; Borstel Germany

2. Tuberculosis Unit; German Center for Infection Research (DZIF); Borstel Germany

3. International Health/Infectious Diseases; University of Lübeck; Lübeck Germany

4. Department of Medicine; Karolinska Institute; Stockholm Sweden

5. Department of Pharmacotherapy and Translational Research; Infectious Disease Pharmacokinetics Laboratory; College of Pharmacy; University of Florida; Gainesville FL USA

6. Department of Medicine; Center for Infectious Medicine (CIM); Karolinska Institutet; Karolinska University Hospital Huddinge; Stockholm Sweden

7. Task Applied Science; Bellville South Africa

8. Division of Physiology; Faculty of Medicine and Health Sciences; Stellenbosch University; Tygerberg South Africa

9. Section of Global and Immigrant Health; Baylor College of Medicine; Houston TX USA

10. Department of Pumonary Diseases & Tuberculosis; University Medical Center Groningen; University of Groningen; Groningen The Netherlands

11. Molecular and Experimental Mycobacteriology; National Reference Center for Mycobacteria; Research Center Borstel; Borstel Germany

12. Cellular Microbiology; Research Center Borstel; Borstel Germany

13. Biochemical Microbiology & Immunochemistry; University of Lübeck; Lübeck Germany

14. LRA INFECTIONS'21; Borstel Germany

15. Department of Infectious Disease Epidemiology; Bernhard Nocht Institute for Tropical Medicine; Hamburg Germany

16. Department of Clinical and Experimental Medicine; Linköping University; Linköping Sweden

17. Department of Clinical Microbiology and Infectious Diseases; Kalmar County Hospital; Linköping University; Linköping Sweden

Funder

Deutsches Zentrum für Infektionsforschung

Vetenskapsrådet

Hjärt-Lungfonden

South African National Research Foundation

Publisher

Wiley

Subject

Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/joim.12780/fullpdf

Reference241 articles.

1. G20 Leaders ́ Declaration Shaping an interconnected world 2017 https://www.g20.org/gipfeldokumente/G20-leaders-declaration.pdf

2. World Health Organisation Largest ever roll-out of GeneXpert ® rapid TB test machines in 21 countries 2013 http://www.who.int/tb/features_archive/xpertprojectlaunch/en/

3. Xpert(R) MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults;Steingart;Cochrane Database Syst Rev,2014

4. The new xpert MTB/RIF Ultra: improving detection of mycobacterium tuberculosis and resistance to rifampin in an assay suitable for point-of-care testing;Chakravorty;MBio,2017

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The integration of omics: A promising approach to personalized tuberculosis treatment;Medicine in Omics;2024-12

2. Implementation of targeted next-generation sequencing for the diagnosis of drug-resistant tuberculosis in low-resource settings: a programmatic model, challenges, and initial outcomes;Frontiers in Public Health;2023-08-03

3. Targeting mycobacterial membranes and membrane proteins: Progress and limitations;Bioorganic & Medicinal Chemistry;2023-03

4. TargetingMycobacterium tuberculosisiron-scavenging tools: a recent update on siderophores inhibitors;RSC Medicinal Chemistry;2023

5. Can digital adherence technologies reduce inequity in tuberculosis treatment success? Evidence from a randomised controlled trial;BMJ Global Health;2022-12